DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT)

J. van der Palen (Enschede, Netherlands), I. Cerveri (Pavia, Italy), N. Roche (Paris, France), D. Singh (Manchester, United Kingdom), V. Plaza (Barcelona, Spain), C. Gonzalez (Valencnia, Spain), O. Patino (Amsterdam, Netherlands), I. Scheepstra (Amsterdam, Netherlands), G. Safioti (Amsterdam, Netherlands), V. Backer (Copenhagen, Denmark)

Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Session: Pulmonary drug delivery: inhaler use, devices and technologies
Session type: Thematic Poster
Number: 1020
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. van der Palen (Enschede, Netherlands), I. Cerveri (Pavia, Italy), N. Roche (Paris, France), D. Singh (Manchester, United Kingdom), V. Plaza (Barcelona, Spain), C. Gonzalez (Valencnia, Spain), O. Patino (Amsterdam, Netherlands), I. Scheepstra (Amsterdam, Netherlands), G. Safioti (Amsterdam, Netherlands), V. Backer (Copenhagen, Denmark). DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT). 1020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: